CatalystFDA/Bio

FDA LAUNCHES PILOT PROGRAM THAT AIMS TO SPEED THE TIME TO FIRST-IN-HUMAN DRUG TRIALS - SEEKINGALPHA

FDA pilot program aims to accelerate first-in-human drug trials, a regulatory catalyst for biotech.

What changed

FDA pilot program aims to accelerate first-in-human drug trials, a regulatory catalyst for biotech.

Why it matters

FDA pilot program aims to accelerate first-in-human drug trials, a regulatory catalyst for biotech. — impact context not separately stored; see What changed.

Sources

seekingalpha